These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26673880)

  • 1. Investigating combination HIV prevention: isolated interventions or complex system.
    Brown G; Reeders D; Dowsett GW; Ellard J; Carman M; Hendry N; Wallace J
    J Int AIDS Soc; 2015; 18(1):20499. PubMed ID: 26673880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative Strategies for Scale up of Effective Combination HIV Prevention Interventions in Sub-Saharan Africa.
    Shanaube K; Bock P
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):231-7. PubMed ID: 25929960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilisation, politics, investment and constant adaptation: lessons from the Australian health-promotion response to HIV.
    Brown G; O'Donnell D; Crooks L; Lake R
    Health Promot J Austr; 2014 Apr; 25(1):35-41. PubMed ID: 24739777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
    Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
    PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Recent HIV Prevention Interventions and Future Considerations for Nursing Science.
    Threats M; Brawner BM; Montgomery TM; Abrams J; Jemmott LS; Crouch PC; Freeborn K; Kamitani E; Enah C
    J Assoc Nurses AIDS Care; 2021 May-Jun 01; 32(3):373-391. PubMed ID: 33929980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV sexual risk reduction interventions for women: a review.
    Wingood GM; DiClemente RJ
    Am J Prev Med; 1996; 12(3):209-17. PubMed ID: 8743877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical research.
    Knight R; Small W; Pakula B; Thomson K; Shoveller J
    BMC Med Ethics; 2014 Jul; 15():54. PubMed ID: 24994501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level.
    Eisinger RW; Dieffenbach CW; Fauci AS
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S171-S172. PubMed ID: 31764250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of reaching the 90-90-90 targets: are current investments enough?
    Kates J; Wexler A; Dieleman J; Moses M; Stover J
    Curr Opin HIV AIDS; 2019 Nov; 14(6):509-513. PubMed ID: 31524657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding of community-based interventions for HIV prevention.
    Poku NK; Bonnel R
    Afr J AIDS Res; 2016 Jul; 15(2):163-71. PubMed ID: 27399046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of HIV prevention.
    Padian NS; Isbell MT; Russell ES; Essex M
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S22-6. PubMed ID: 22772385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination HIV prevention options for young women in Africa.
    Baxter C; Abdool Karim S
    Afr J AIDS Res; 2016 Jul; 15(2):109-21. PubMed ID: 27399041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact.
    Velloza J; Delany-Moretlwe S; Baeten JM
    Curr Opin HIV AIDS; 2019 Sep; 14(5):423-432. PubMed ID: 31261158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries.
    Ota E; Wariki WM; Mori R; Hori N; Shibuya K
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006045. PubMed ID: 22161397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.